Watch: Pfizer Executive Admits On Camera ‘Mutate’ COVID via ‘Directed Evolution’ To Profit From Vaccines

‘Mutate’ COVID via ‘Directed Evolution’ for Company to Continue Profiting Off of Vaccines… ‘COVID is Going to be a Cash Cow for Us’… ‘That is Not What We Say to the Public’ … ‘People Won’t Like That’ … ‘Don’t Tell Anyone’.

  • “One of the things we’re researching is like, why don’t we just mutate it [COVID] ourselves so we could make — preemptively produce new vaccines, right?” said Jordon Trishton Walker, Pfizer Director of Research and Development, Strategic Operations – mRNA Scientific Planner. That is what we must do. However, there is a risk involved if we do that. As you can understand, nobody wants a pharmaceutical firm-altering virus.
  • Don’t tell anyone, Walker warned. Make a commitment not to inform anyone. The experiment would include infecting monkeys with the virus, causing them to keep infecting each other, and then taking serial samples from them.
  • Walker: “You have to be really cautious to make sure that the COVID virus you mutate doesn’t produce anything that spreads indiscriminately. To be honest, I believe that this is how the virus first appeared in Wuhan. The sudden appearance of this pathogen defies logic. It is nonsense.”
  • “From what I’ve heard, they [Pfizer scientists] are optimizing it [the COVID mutation process], but they’re going slow because everyone is extremely cautious — clearly they don’t want to accelerate it too quickly,” said Walker. Since it is evident that you do not want to announce that you are researching potential future mutations, I believe they are also just attempting to do it as an exploratory thing.

NEW YORK – 25 January 2023: Jordon Trishton Walker, a Pfizer executive, reveals that his company is looking into ways to “mutate” COVID via “Directed Evolution” in order to delay the creation of subsequent vaccines. Project Veritas has now released a new video exposing Walker.

According to Walker, Gain-of-Function, which is defined as “a mutation that imparts new or enhanced activity on a protein,” is distinct from directed evolution. In other words, it implies that, depending on the mutation or scientific experiment carried out on it, a virus like COVID may become more potent.

The Pfizer executive discussed his company’s plans for COVID vaccines with a Veritas journalist while noting that if this information became public, people would not be pleased.

“One of the things Pfizer is investigating is like, why don’t we just mutate it [COVID] ourselves so we could build — produce new vaccines beforehand, right? That is what we must do. But if we do that, there’s a risk that, as you might guess, nobody wants a pharmaceutical corporation altering viruses,” Walker added.

According to what I’ve heard, the COVID mutation process is being optimized by Pfizer experts, but they’re moving slowly since everyone is being quite cautious — clearly, they don’t want to accelerate it too quickly. You obviously don’t want to publicize that you are figuring out future mutations, so I believe they are just trying to do it as an experimental activity,” he said.

“Don’t tell anyone. Promise you won’t tell anyone. The way it [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them.”

Walker drew parallels between this current Pfizer project and what may have happened at the Wuhan Institute of Virology in China.

“You have to be very controlled to make sure that this virus [COVID] that you mutate doesn’t create something that just goes everywhere. Which, I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere. It’s bullsh*t,” he said.

“You’re not supposed to do Gain-of-Function research with viruses. Regularly not. We can do these selected structure mutations to make them more potent. There is research ongoing about that. I don’t know how that is going to work. There better not be any more outbreaks because Jesus Christ,” he said.

Walker also told the Veritas journalist that COVID has been instrumental for Pfizer’s recent business success:

Walker: Part of what they [Pfizer scientists] want to do is, to some extent, to try to figure out, you know, how there are all these new strains and variants that just pop up. So, it’s like trying to catch them before they pop up and we can develop a vaccine prophylactically, like, for new variants. So, that’s why they like, do it controlled in a lab, where they say this is a new epitope, and so if it comes out later on in the public, we already have a vaccine working.

Veritas Journalist: Oh my God. That’s perfect. Isn’t that the best business model though? Just control nature before nature even happens itself? Right?

Walker: Yeah. If it works.

Veritas Journalist: What do you mean if it works?

Walker: Because some of the times there are mutations that pop up that we are not prepared for. Like with Delta and Omicron. And things like that. Who knows? Either way, it’s going to be a cash cow. COVID is going to be a cash cow for us for a while going forward. Like obviously.

Veritas Journalist: Well, I think the whole research of the viruses and mutating it, like, would be the ultimate cash cow.

Walker: Yeah, it’d be perfect.

Walker continued by outlining how it is not in the interests of the American people for Big Pharma and government officials, such as those at the Food & Drug Administration [FDA], to have common goals:

Walker: [Big Pharma] is a revolving door for all government officials.

Veritas Journalist: Wow.

Walker: In any industry though. So, in the pharma industry, all the people who review our drugs — eventually most of them will come work for pharma companies. And in the military, defense government officials eventually work for defense companies afterwards.

Veritas Journalist: How do you feel about that revolving door?

Walker: It’s pretty good for the industry to be honest. It’s bad for everybody else in America.

Veritas Journalist: Why is it bad for everybody else?

Walker: Because when the regulators reviewing our drugs know that once they stop regulating, they are going to work for the company, they are not going to be as hard towards the company that’s going to give them a job.

Source: Project Veritas

About Author